SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

BrokeCoin is a meme-meets-utility cryptocurrency project operating under the ethos of Transparency, Community, and Respect. Formally registered as an LLC in Wyoming, USA, BrokeCoin is building an expansive ecosystem that combines light-hearted spirit of meme culture with real-world crypto utilities—spanning gaming, staking, NFTs, web services, and an e-commerce platform. Brokecoin believes in developing useful and interesting meme-inspired utilities to both service the crypto industry, and generate value for holders.

Brokecoin

Brokecoin is trending as the community rallies around its 10-month anniversary and recent listings, emphasizing its resilience in the meme coin space. Discussions highlight the project's utility, staking on BiFinance, play-to-earn games, and community-driven initiatives. The community is focused on the project's comeback, and building towards new all-time highs.

Solana is a highly functional open source project that banks on blockchain technology’s permissionless nature to provide decentralized finance (DeFi) solutions. It is a layer 1 network that offers fast speeds and affordable costs. While the idea and initial work on the project began in 2017, Solana was officially launched in March 2020 by the Solana Foundation with headquarters in Geneva, Switzerland.

Solana

Solana is trending amid discussions around meme coins and Phantom Wallet integrations, with the community highlighting specific tokens like $SOLYCAT and $ROSIE. Recent chatter also points to potential growth catalysts like a Fidelity listing and integrations with projects like $IMG, generating optimism within the Solana ecosystem. Some traders are keeping a close eye on technical levels for potential breakouts.

The SolyCat is a symbol of energy and mystery. Shining like the sun and agile as a feline.  Solycat is here to take over Solana! Inspired by Shiba Inu’s legendary rise on Ethereum, Solycat is the ultimate meme coin designed for Solana’s fast and scalable blockchain.  Our mission is simple: become the top cat of Solana. With bold branding, a vibrant community, and unstoppable momentum, Solycat is ready to dominate. This isn’t just another token—it’s a movement powered by fun, creativity, and the spirit of decentralization.  Join the pride and let’s make history, one paw at a time!

Solycat

Solycat ($SOLYCAT) is gaining attention, particularly within the Phantom Wallet community, where it's being touted as a potential gem. The community is using terms like "moon," "rocket," and "breakout" to describe the token's recent price action and momentum.

Ripple is the catchall name for the cryptocurrency platform, the transactional protocol for which is actually XRP, in the same fashion as Ethereum is the name for the platform that facilitates trades in Ether. Like other cryptocurrencies, Ripple is built atop the idea of a distributed ledger network which requires various parties to participate in validating transactions, rather than any singular centralized authority. That facilitates transactions all over the world, and transfer fees are far cheaper than the likes of bitcoin. Unlike other cryptocurrencies, XRP transfers are effectively immediate, requiring no typical confirmation time.  Ripple was originally founded by a single company, Ripple Labs, and continues to be backed by it, rather than the larger network of developers that continue bitcoin’s development. It also doesn’t have a fluctuating amount of its currency in existence. Where bitcoin has a continually growing pool with an eventual maximum, and Ethereum theoretically has no limit, Ripple was created with all of its 100 billion XRP tokens right out of the gate. That number is maintained with no mining and most of the tokens are owned and held by Ripple Labs itself — around 60 billion at the latest count.  Even at the recently reduced value of around half a dollar per XRP, that means Ripple Labs is currently sitting on around $20 billion worth of the cryptocurrency (note: Ripple’s price crashed hard recently, and may be worth far less than $60 billion by time you read this). It holds 55 billion XRP in an escrow account, which allows it to sell up to a billion per month if it so chooses in order to fund new projects and acquisitions. Selling such an amount would likely have a drastic effect on the cryptocurrency’s value, and isn’t something Ripple Labs plans to do anytime soon.  In actuality, Ripple Labs is looking to leverage the technology behind XRP to allow for faster banking transactions around the world. While Bitcoin and other cryptocurrencies are built on the idea of separating financial transactions from the financial organizations of traditional currencies, Ripple is almost the opposite in every sense.  XRP by Ripple price can be found on this page alongside the market capitalization and additional stats.

Ripple

XRP is trending as the community discusses potential catalysts, including Ripple's recent acquisition and the possibility of XRP ETFs, while also considering the broader market context and potential impact of the government shutdown. Bullish sentiment is fueled by anticipation of increased institutional adoption and reduced circulating supply, though some traders remain cautious, citing historical price patterns and market manipulation. Community members are actively debating potential price targets and the timing of the next significant price movement.

Jump into the crypto fun with $SOLCAT! Our token features a savvy cat wearing a fabulous Solana hat, offering super cool adventures in the world of meme coins.

CatSolHat

CatSolHat ($SOLCAT) is trending as the community rallies around this Solana-based meme coin. The coin is being touted as 'Solana's sleekest predator' as social media users encourage others to 'join the pride'. It's also being discussed in relation to other meme coins like $PEPE.

Grayscale Bitcoin Mini Trust ETF - Common units of fractional undivided beneficial interest

Grayscale Bitcoin Mini Trust ETF

Grayscale Bitcoin Mini Trust ETF is trending amid discussions about Bitcoin's recent price movements, particularly its approach to all-time highs and potential for further gains. Community members are weighing in on factors like institutional investment, regulatory developments, and the impact of potential government shutdowns, while also debating whether Bitcoin is a safe haven asset or a speculative investment. There is active speculation on short squeezes, market manipulation, and potential rotation into other assets like gold.

USDC is a fully collateralized US dollar stablecoin. USDC is the bridge between dollars and trading on cryptocurrency exchanges. The technology behind CENTRE makes it possible to exchange value between people, businesses and financial institutions just like email between mail services and texts between SMS providers. We believe by removing artificial economic borders, we can create a more inclusive global economy.

USD Coin

USD Coin is trending amidst discussions around stablecoin regulation and adoption, with the community actively debating its role in the evolving crypto landscape. Key talking points include Circle's initiatives, such as developer bounties, and the potential impact of upcoming legislation like the GENIUS Act. Furthermore, USDC is being compared to other stablecoins and digital assets like USDT and memecoins, specifically in regards to treasury strategies and market movements.

Procter & Gamble Co. engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances. The Health Care segment includes oral care products like toothbrushes, toothpaste, and personal health care such as gastrointestinal, rapid diagnostics, respiratory, and vitamins, minerals, and supplements. The Fabric and Home care segment consists of fabric enhancers, laundry additives and detergents, and air, dish, and surface care. The Baby, Feminine and Family Care segment sells baby wipes, diapers, and pants, adult incontinence, feminine care, paper towels, tissues, and toilet paper. The company was founded by William Procter and James Gamble in 1837 and is headquartered in Cincinnati, OH.

Procter & Gamble Co.

Procter & Gamble is trending as investors digest a Q1 earnings beat driven by pricing power and strong segment growth, although some are concerned about tariff headwinds impacting future margins. The community is discussing the potential for price target increases and whether the recent solid quarter is enough to overcome year-to-date underperformance. Bullish sentiment is building as the stock trades near its 52-week low despite positive earnings news, while some analysts suggest defensive plays in the consumer staples sector are poised to outperform.

Rigel Pharmaceuticals, Inc. operates as a clinical stage biotechnology company. It discovers and develops novel, targeted drugs in the therapeutic areas of immunology, oncology and immune oncology. The firm focuses on intracellular signalling pathways and related targets that are critical to disease mechanisms. The company's products include Tavalisse, Fostamatinib and R835. Rigel Pharmaceuticals was founded by Donald G. Payan, James M. Gower, Thomas A. Raffin, Garry P. Nolan and Ronald B. Garren on June 14, 1996 and is headquartered in South San Francisco, CA.

Rigel Pharmaceuticals

RIGL is trending as investors discuss potential catalysts, including upcoming earnings and clinical trial updates, that could drive the stock higher. Bullish sentiment revolves around the company's strong fundamentals, low P/E ratio, and potential for a short squeeze, while some community members also speculate about a possible buyout. Community members are closely watching share price movements to determine entry or exit points, but many long-term holders are planning to hold despite the volatility.

Ventyx Biosciences, Inc. engages in developing novel small molecule therapeutics for the treatment of autoimmune diseases. Its clinical stage pipeline includes VTX958, a Phase 1 allosteric TYK2 inhibitor for the treatment of a broad range of autoimmune diseases, VTX002, a Phase 2-ready S1P1 receptor modulator for the treatment of ulcerative colitis, and VTX2735, a Phase 1-ready peripheral inhibitor of the NLRP3 inflammasome, which is a mediator of multiple inflammatory conditions. The company was founded by Raju S. Mohan on November 21, 2018 and is headquartered in San Diego, CA.

Ventyx Biosciences Inc

Ventyx Biosciences is trending following positive trial news, driving a surge in price and trading volume. The community is focused on the potential for further gains and a possible short squeeze, while some traders caution about resistance levels and potential profit-taking. Discussions also include the possibility of a future offering to capitalize on the increased price.

statis crypto Watchlist

Bitcoin

Ethereum

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

TrueBlue to Announce Third Quarter 2025 Results

TrueBlue (NYSE: TBI) will release third quarter 2025 earnings results after the market close on Monday, Nov. 3, 2025. Management will discuss the results on a webcast at 2:00 p.m. PT (5:00 p.m. ET...

TrueBlue (TBI) Upgraded to Buy: Here's What You Should Know

TrueBlue (TBI) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

TrueBlue (TBI) Reports Q2 Loss, Misses Revenue Estimates

TrueBlue (TBI) delivered earnings and revenue surprises of +77.42% and -0.02%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Insperity, Inc. (NSP) Lags Q2 Earnings and Revenue Estimates

Insperity (NSP) delivered earnings and revenue surprises of -36.59% and -0.54%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

TrueBlue Reports Fourth Quarter and Full-Year 2024 Results

TrueBlue (NYSE:TBI) today announced its fourth quarter and full-year results for 2024. Fourth Quarter 2024 Financial Highlights Revenue of $386 million compared to $492 million in the prior year...

TrueBlue's Staff Management  SMX Brand Receives Diamond Distinction for Decade of Service Excellence with ClearlyRated 2025 Best of Staffing Awards

TrueBlue's Staff Management | SMX Brand Receives Diamond Distinction for Decade of Service Excellence with ClearlyRated 2025 Best of Staffing Awards TrueBlue's Staff Management | SMX Brand Receives...

TMP Worldwide UK to Provide Recruitment Services for Serco in Landmark UK Armed Forces Contract

TMP Worldwide UK, the UKs largest recruitment marketing agency, will provide employer brand and candidate attraction services for the UKs Armed Forces as a delivery partner to Serco. The appointment...

TrueBlue to Announce Fourth Quarter and Full-Year 2024 Results

TrueBlue (NYSE: TBI) will release fourth quarter and full-year 2024 earnings results after the market close on Wednesday, Feb. 19, 2025. Management will discuss the results on a webcast at 2:00 p.m...

TrueBlue Accelerates Diversification into Attractive Healthcare Industry with Accretive Acquisition of Healthcare Staffing Professionals, Inc.

TrueBlue Inc. (NYSE: TBI), a leading provider of specialized workforce solutions, today announced the off-market acquisition of high-growth Healthcare Staffing Professionals, Inc. (HSP), a long-term...

TrueBlue's PeopleScout Advances Proprietary Talent Tech Affinix with AI-Powered Capabilities and Modular Design

TrueBlue's PeopleScout Advances Proprietary Talent Tech Affinix with AI-Powered Capabilities and Modular Design TrueBlue's PeopleScout Advances Proprietary Talent Tech Affinix with AI-Powered...

TrueBlue, Inc. engages in the provision of staffing, recruitment process outsourcing and managed service provider solutions. It operates through the following segments: PeopleReady, PeopleManagement, and PeopleScout. The PeopleReady segment offers staffing solutions for blue-collar, contingent on-demand and skilled labor to a broad range of industries that include retail, manufacturing, warehousing, logistics, energy, construction, hospitality and others. The PeopleManagement segment supplies contingent labor and outsourced industrial workforce solutions. The PeopleScout segment covers the provision of permanent employee recruitment process outsourcing for its customers for all major industries and jobs. The company was founded by John Ross Coghlan and Glenn Welstad in 1989 and is headquartered in Tacoma, WA.

TrueBlue Inc

Cut 25 bps

Cut 50+ bps

No change

What will the Fed decide at its October meeting? Polymarket gives a 92% chance of a 25 bps cut. 
 
*Powered by Polymarket

Current Price	N/A
Prev Close	N/A
Open	N/A
Dividend Yield	0.00%
50-Day Moving Average	$5.93
Beta	0.86
Avg. Volume	171,928.90
PE Ratio	-5.19

52-Week High	$9.05
52-Week Low	$3.45
Market Capitalization	$177.01M
EPS (Annual)	-$4.17
Price to Book	0.58
Revenue Per Employee	$373,188.81
Enterprise Value/EBITDA	N/A

TBI
TrueBlue Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest TBI News

TBITrueBlue Inc